| *Global Vaccine and Immunization Research Forum: Opportunities and challenges in vaccine discovery, development, and delivery | Andrew Ford, Angela Hwang, B. Fenton Hall, Joachim Hombach, Nancy Touchette | 2016 | Journal article | English |
| Agenda - GVIRF 2014 | GVIRF Secretariat | 2014 | Presentation | English |
| KN1 Opening Session and Keynote | Anthony Fauci | 2014 | Report | English |
| KN1.1 Vaccine Research and Development: Challenges and Opportunities | Anthony Fauci | 2014 | Presentation | English |
| KN1.2 R&D in the "Decade of Vaccines" | B. Fenton Hall | 2014 | Presentation | English |
| KN1.3 GVIRF Overview and Goals | Joachim Hombach | 2014 | Presentation | English |
| KN1.4 What do we expect from the meeting? | José Esparza | 2014 | Presentation | English |
| KN2 Research for Universal Health Coverage; Perspective on Vaccines and Poverty Reduction | Margaret Chan, Tim Evans | | Report | English |
| KN2.1 WHO Director-General address to GVIRF | Margaret Chan | 2014 | Presentation | English |
| KN2.2 Perspectives on Vaccines and Poverty Reduction | T. Evans, World Bank | 2014 | Presentation | English |
| KN3 Importance of Innovation in Addressing Global Health Gaps in the Developing World | Trevor Mundel | | Report | English |
| KN3-1 The Importance of Innovation in Addressing Global Health Gaps in the Developing World | Trevor Mundel | | Presentation | English |
| P1a.1 Status of HIV Vaccine Research & Development | Wayne Koff | 2014 | Presentation | English |
| P1a.2 Progress towards the development of an HIV vaccine: Discussion | José Esparza | 2014 | Presentation | English |
| P1b Develop New and Improved Vaccines - TB | Charles Mgone, Tom Evans, Uli Fruth | 2014 | Report | English |
| P1b.1 Update on Tuberculosis Vaccines - 2014 | Tom Evans | 2014 | Presentation | English |
| P1b.2 TB Vaccine Development: Challenges & Opportunities | Uli Fruth | 2014 | Presentation | English |
| P1c Develop New and Improved Vaccines - Malaria | Ashley Birkett, Charles Mgone, Peter Smith | 2014 | Report | English |
| P1c.1 Progress towards the development of a malaria vaccine | Ashley Birkett | 2014 | Presentation | English |
| P1c.2 Progress towards the development of a malaria vaccine: discussion | Peter Smith | 2014 | Presentation | English |
| P2 Regulatory and Public Health Challenges for Vaccines Inducing Modest Efficacy | David Salisbury | 2014 | Report | English |
| P2.1 Regulatory and public health challenges | Peter Smith | 2014 | Presentation | English |
| P2.2 Regulatory Considerations for Determining Vaccine Efficacy | Marion Gruber | 2014 | Presentation | English |
| P3 Developing Next Generation Vaccines: Defining the Improvements Needed and Evaluating Their Potential | K. Neuzil | 2014 | Report | English |
| P3.1 Developing next generation vaccines: Introduction | Kathleen Neuzil | 2014 | Presentation | English |
| P3.2 Developing Country Vaccine Manufacturers - Access to Immunization | Umesh Parashar | 2014 | Presentation | English |
| P3.3 Developing Next Generation Rotavirus Vaccines: Prospects from the Pipeline to Address Remaining Public Health Needs | Mary K. Estes | 2014 | Presentation | English |
| P3.4 Evaluation of the Next Generation of Rotavirus Vaccines | Kathleen Neuzil | 2014 | Presentation | English |
| P5 Research to improve monitoring and evaluation of immunization programs | Jean-Marie Okwo-Bele | 2014 | Report | English |
| P5.1 Immunization Registries in Latin America and the Caribbean | M. Carolina Danovaro-Holliday | 2014 | Presentation | English |
| P5.2 Influenza Vaccine Use in the Americas: Network for Evaluation of Influenza Vaccine Effectiveness REVELAC-1 | Alba Maria Ropero-Alvarez | 2014 | Presentation | English |
| P6 Protection of pregnant women, neonates and infants by maternal immunization | Helen Rees | 2014 | Report | English |
| P6.1 Public Health Benefits of Maternal Immunization | Keith Klugman | 2014 | Presentation | English |
| P6.2 Maternal Immunization: which impact on infant immunity? | Claire-Anne Siegrist | 2014 | Presentation | English |
| P7 Innovative vaccine research: the point of view of industry and biotech companies | Michael Mowatt, Odile Leroy | | Report | English |
| P7.1 Innovation for vaccines against poverty diseases: the need for new support mechanisms | Martin Friede | 2014 | Presentation | English |
| P8 General Conclusion | B. Fenton Hall, Chris Wilson, Jean-Marie Okwo-Bele | 2014 | Report | English |
| W1 Towards the Development of a Universal Influenza Vaccine | David Spiro | 2014 | Report | English |
| W1.1 Towards the Development of a Universal Influenza Vaccine | David Spiro | 2014 | Presentation | English |
| W2 Preferred Product Characteristics (PPC) as a Way to Guide Development of Products of High Public Health Utility | A. A. Adeyemo | 2014 | Report | English |
| W2.1 WHO Preferred Product Characteristics: Bridging Vaccine R&D with Public Health | Vasee Moorthy | 2014 | Presentation | English |
| W2.2 RSV Vaccine Development for Low and Middle Income Countries: Challenges and Progress | Claudio Lanata | 2014 | Presentation | English |
| W2.3 Group A streptococcal vaccines: Challenges and progress | Florian Schödel | 2014 | Presentation | English |
| W3.1 Leishmania Vaccine Development: Progress and challenges in the context of other control strategies | Farrokh Modabber | 2014 | Presentation | English |
| W3.2 Pre-exposure rabies vaccination (PreP) in children of endemic countries | D. Briggs | 2014 | Presentation | English |
| W4 How to Optimize Immunization Coverage? A case study from Measles-Rubella vaccination | A. A. Adeyemo | 2014 | Report | English |
| W4.1 Progress, Challenges, and Lessons Learned in Achieving Measles and Rubella Goals | Thomas Cherian | 2014 | Presentation | English |
| W4.2 Prioritizing the Research Agenda for Measles and Rubella | William Moss | 2014 | Presentation | English |
| W5.1 Immunization implementation research priority setting | John Clemens | 2014 | Presentation | English |
| W5.2 Factors influencing community health volunteers in participating in health programs in Africa | Fadima YAYA BOCOUM | 2014 | Presentation | English |
